4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-009272
EVP, COO, HEAD OF COMMERCIAL sold 5,140 shares at $17.90 ($92,006)
- EVP, COO, HEAD OF COMMERCIAL acquired 10,048 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-03-25 | Grant or award | +10,048 | 41,480 | D | ||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-03-27 | Sale | −5,140 | $17.90 | $92,006 | 36,340 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-03-25 | Grant or award · Stock Options (Right to Buy) | +89,516 | 89,516 | D | ||
| Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2024-03-25 | Grant or award · Restricted Stock Units | +27,460 | 27,460 | D | ||
| Open-market sales · 5,140 sh · avg $17.90 · $92,006 | |||||||
Loading xslF345X05/form4-03272024_110355.xml…